Your browser doesn't support javascript.
loading
Variations in MicroRNA-25 Expression Influence the Severity of Diabetic Kidney Disease.
Liu, Yunshuang; Li, Hongzhi; Liu, Jieting; Han, Pengfei; Li, Xuefeng; Bai, He; Zhang, Chunlei; Sun, Xuelian; Teng, Yanjie; Zhang, Yufei; Yuan, Xiaohuan; Chu, Yanhui; Zhao, Binghai.
Afiliação
  • Liu Y; Heilongjiang Key Laboratory of Anti-Fibrosis Biotherapy, Medical Research Center, Heilongjiang, People's Republic of China; and.
  • Li H; Clinical Laboratory of Hong Qi Hospital, Mudanjiang Medical University, Heilongjiang, People's Republic of China.
  • Liu J; Heilongjiang Key Laboratory of Anti-Fibrosis Biotherapy, Medical Research Center, Heilongjiang, People's Republic of China; and.
  • Han P; Heilongjiang Key Laboratory of Anti-Fibrosis Biotherapy, Medical Research Center, Heilongjiang, People's Republic of China; and.
  • Li X; Clinical Laboratory of Hong Qi Hospital, Mudanjiang Medical University, Heilongjiang, People's Republic of China.
  • Bai H; Clinical Laboratory of Hong Qi Hospital, Mudanjiang Medical University, Heilongjiang, People's Republic of China.
  • Zhang C; Heilongjiang Key Laboratory of Anti-Fibrosis Biotherapy, Medical Research Center, Heilongjiang, People's Republic of China; and.
  • Sun X; Heilongjiang Key Laboratory of Anti-Fibrosis Biotherapy, Medical Research Center, Heilongjiang, People's Republic of China; and.
  • Teng Y; Heilongjiang Key Laboratory of Anti-Fibrosis Biotherapy, Medical Research Center, Heilongjiang, People's Republic of China; and.
  • Zhang Y; Heilongjiang Key Laboratory of Anti-Fibrosis Biotherapy, Medical Research Center, Heilongjiang, People's Republic of China; and.
  • Yuan X; Heilongjiang Key Laboratory of Anti-Fibrosis Biotherapy, Medical Research Center, Heilongjiang, People's Republic of China; and.
  • Chu Y; Heilongjiang Key Laboratory of Anti-Fibrosis Biotherapy, Medical Research Center, Heilongjiang, People's Republic of China; and.
  • Zhao B; Heilongjiang Key Laboratory of Anti-Fibrosis Biotherapy, Medical Research Center, Heilongjiang, People's Republic of China; and yanhui_chu@163.com zhaobinghai01@163.com.
J Am Soc Nephrol ; 28(12): 3627-3638, 2017 Dec.
Article em En | MEDLINE | ID: mdl-28923913
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Regulação da Expressão Gênica / MicroRNAs / Diabetes Mellitus Tipo 1 / Diabetes Mellitus Tipo 2 / Nefropatias Diabéticas Limite: Animals / Humans / Male Idioma: En Ano de publicação: 2017 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Regulação da Expressão Gênica / MicroRNAs / Diabetes Mellitus Tipo 1 / Diabetes Mellitus Tipo 2 / Nefropatias Diabéticas Limite: Animals / Humans / Male Idioma: En Ano de publicação: 2017 Tipo de documento: Article